Skip to content

Medical emergency? What to do

Bristol-Myers sending AIDS doctors to Africa

3-RXPublished August 19, 20062 min read

Key points

  • U.S. drug giant Bristol-Myers Squibb Co. is sending 250 pediatric doctors over the next five years to sub-Saharan Africa to fight HIV/AIDS, part of a growing push to target infants and children in the battle against the epidemic.
  • The United Nations AIDS agency UNAIDS estimates that 2.3 million children under 15 years of age were living with HIV in 2005, nearly 90 percent of whom live in sub-Saharan Africa.
  • Medecins Sans Frontieres, also known as Doctors Without Borders, called this week for a refocusing on mother-to-child HIV transmissions, pointing to a lack of affordable pediatric treatments and proper diagnostic tools.
  • Mark Kline, president of the Baylor International Pediatric AIDS Initiative, said the push towards pediatric treatment represented a "hopeful and exciting" time for pediatric AIDS work.

U.S. drug giant Bristol-Myers Squibb Co. is sending 250 pediatric doctors over the next five years to sub-Saharan Africa to fight HIV/AIDS, part of a growing push to target infants and children in the battle against the epidemic.

The initiative is a joint venture with the Baylor College of Medicine in Houston, Texas, and was announced Wednesday at the 16th International AIDS Conference in Toronto.

The United Nations AIDS agency UNAIDS estimates that 2.3 million children under 15 years of age were living with HIV in 2005, nearly 90 percent of whom live in sub-Saharan Africa.

The venture, part of the Secure the Future campaign launched by Bristol-Myers in 1999, will also include a program to prevent mother-to-child transmission of HIV and the opening of children's clinics.

Medecins Sans Frontieres, also known as Doctors Without Borders, called this week for a refocusing on mother-to-child HIV transmissions, pointing to a lack of affordable pediatric treatments and proper diagnostic tools.

On Tuesday, former President Clinton called on policymakers to push for more pediatric treatments, and said he thought funding for pediatric medicine would become a greater priority over the next two years.

Mark Kline, president of the Baylor International Pediatric AIDS Initiative, said the push towards pediatric treatment represented a "hopeful and exciting" time for pediatric AIDS work.

"We have an opportunity to scale up these programs and to see hundreds of thousands or millions of children benefit over the coming years," he told a news conference.

Peter Singer, senior scientist with the University of Toronto's McLaughlin Centre for Molecular Medicine, said private sector initiatives such as Secure the Future are necessary due to the sheer magnitude of the AIDS epidemic.

"HIV/AIDS is really the mother of all ethical challenges, he said.

"It's not purely one that the government sector or civil society alone can tackle, and the private sector needs to be a constructive contributor."

As part of the project, 50 pediatric AIDS doctors will arrive in clinics by next Monday to begin one-year assignments, the kickoff to a campaign to prevent mother-to-child transmission of HIV.

Bristol-Myers, which has so far committed about $150 million to the Secure the Future program, including $32 million to the latest initiative, will send 50 doctors each year over the next five years.

Baylor is contributing $10 million to the project.

The doctors will train local health care personnel, and are expected to treat an estimated 80,000 children.

Secure the Future has already seen strong results with its network of children's clinical centers, which Kline says has brought down death rates and hospitalization rates.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underAIDS/HIV

Keep reading

AIDS/HIV

Economic crisis could worsen HIV/AIDS epidemic: UN

Economic crisis and climate change concerns could affect the fight against the AIDS virus and lead to a "universal nightmare", the head of the United Nations' agency for HIV/AIDS said on Sunday. The global economic…

2 min read

AIDS/HIV

Possible cure for HIV patients?

On December 7th, an article was published in PLoS One that explained that researchers from UCLA AIDS Institute have found a way to use human stem cells to fight HIV-infected cells. The human stem cells can be…

1 min read

AIDS/HIV

HIV-infected Chinese children struggle with stigma

The second storey of this nondescript building in Fuyang city in China's central province of Anhui houses HIV-positive orphans, but unlike many other similar establishments, there are no signboards outside. Heavy…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.